{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:20Z","timestamp":1786374800231,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.2459\/jcm.0b013e32833cdca8","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:56:31Z","timestamp":1283331391000},"page":"906-911","source":"Crossref","is-referenced-by-count":39,"title":["Cardiological features in idiopathic inflammatory myopathies"],"prefix":"10.2459","volume":"11","author":[{"given":"Chiara","family":"Bazzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Vizzardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Dei Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210207","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: Parts 1 and 2.","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-5-20210207","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"R4-5-20210207","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002281-200211000-00004","article-title":"Inclusion body myositis","volume":"14","author":"Tawil","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"R5-5-20210207","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R6-5-20210207","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"Tanimoto","year":"1995","journal-title":"J Rheumatol"},{"key":"R7-5-20210207","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"key":"R8-5-20210207","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780271011","article-title":"Multiplicity of antibodies in myositis sera","volume":"27","author":"Reichlin","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R9-5-20210207","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R10-5-20210207","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis and therapy","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann Int Med"},{"key":"R11-5-20210207","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0889-857X(21)00070-3","article-title":"Immune manifestations of inflammatory muscle disease","volume":"20","author":"Targoff","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"R12-5-20210207","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/art.1780390218","article-title":"Sensitivity and specificity of anti-Jo1 antibodies in autoimmune diseases with myositis","volume":"39","author":"Vasquez-Abad","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R13-5-20210207","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11926-008-0053-2","article-title":"Autoantibodies and their significance in myositis","volume":"10","author":"Targoff","year":"2008","journal-title":"Curr Rheum Rep"},{"key":"R14-5-20210207","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","article-title":"Clinical utility of antisignal recognition particle antibody in the differential diagnosis of myopathies","volume":"47","author":"Suzuki","year":"2008","journal-title":"Rheumatology"},{"key":"R15-5-20210207","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-5-20210207","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Antisignal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R17-5-20210207","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential of the idiopathic inflammatory myopathies","volume":"249","author":"Hengstman","year":"2002","journal-title":"J Neurol"},{"key":"R18-5-20210207","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":"Antisignal recognition particle autoantibodies: marker of a necrotising myopathy","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R19-5-20210207","first-page":"1991","article-title":"Sclerodermapolymyositis overlap syndrome associated with anti-Ku antibodies and rimmed vacuole formation","volume":"23","author":"Yamanishi","year":"1996","journal-title":"J Rheumatol"},{"key":"R20-5-20210207","first-page":"1393","article-title":"Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients","volume":"29","author":"Franceschini","year":"2002","journal-title":"J Rheumatol"},{"key":"R21-5-20210207","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"R22-5-20210207","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies III: immunoelectron microscopy aspects of cell-mediated muscle fibre injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann Neurol"},{"key":"R23-5-20210207","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"31","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"R24-5-20210207","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00002281-199511000-00007","article-title":"T cell-mediated immune mechanisms in myositis","volume":"7","author":"O'Hanlon","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"R25-5-20210207","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28(null) T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"R26-5-20210207","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780330713","article-title":"Interleukin1 alpha, interleukin 2 and soluble interleukin 2 receptors in polymyositis","volume":"33","author":"Wolf","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R27-5-20210207","first-page":"41","article-title":"Dual effects of caspase 1, interleukin 1 beta, tumor necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies","volume":"21","author":"Mackiewicz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R28-5-20210207","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051165","article-title":"Tumor necrosis factor alpha expression in muscles of polymyositis and dermatomyositis","volume":"99","author":"Kuru","year":"2000","journal-title":"Acta Neuropathol"},{"key":"R29-5-20210207","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00401-002-0635-4","article-title":"Expression of tumor necrosis factor alpha in regenerating muscle fibers in inflammatory and noninflammatory myopathies","volume":"105","author":"Kuru","year":"2003","journal-title":"Acta Neuropathol"},{"key":"R30-5-20210207","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(96)00280-8","article-title":"Expression of tumor necrosis factor-alpha in muscles in polymyositis","volume":"146","author":"Tateyama","year":"1997","journal-title":"J Neurol Sci"},{"key":"R31-5-20210207","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","article-title":"Expression of cell adhesion molecules in inflammatory myopathies","volume":"59","author":"Tews","year":"1995","journal-title":"J Neuroimmunol"},{"key":"R32-5-20210207","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1164\/ajrccm.152.5.7582314","article-title":"TNFalfa mRNA expression in diaphragm muscle after endotoxin administration","volume":"152","author":"Shindoh","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-5-20210207","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/intimm\/12.9.1329","article-title":"Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation","volume":"12","author":"De Rossi","year":"2000","journal-title":"Int Immunol"},{"key":"R34-5-20210207","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/eji.1830270909","article-title":"Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kB","volume":"27","author":"Dhawan","year":"1997","journal-title":"Eur J Immunol"},{"key":"R35-5-20210207","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.177.5.1277","article-title":"Tumor necrosis factor alpha (TNFalfa)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55","volume":"177","author":"MacKay","year":"1993","journal-title":"J Exp Med"},{"key":"R36-5-20210207","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1096\/fasebj.6.8.1592209","article-title":"Cytokine regulation of endothelial cell function","volume":"6","author":"Mantovani","year":"1992","journal-title":"FASEB J"},{"key":"R37-5-20210207","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-201x.2001.00822.x","article-title":"The physiology of inflammatory myopathies: an overview","volume":"171","author":"Lundberg","year":"2001","journal-title":"Acta Physiol Scand"},{"key":"R38-5-20210207","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R39-5-20210207","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/j.1460-2075.1996.tb00524.x","article-title":"Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibition of nitric oxide synthesis and antioxidants","volume":"15","author":"Buck","year":"1996","journal-title":"EMBO J"},{"key":"R40-5-20210207","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","article-title":"Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies","volume":"9","author":"De Bleecker","year":"1999","journal-title":"Neuromusc Disord"},{"key":"R41-5-20210207","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/01913120802209379","article-title":"Tubuloreticular structures in different types of myositis: implications for pathogenesis","volume":"32","author":"Bronner","year":"2008","journal-title":"Ultrastruct Pathol"},{"key":"R42-5-20210207","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.autrev.2009.02.026","article-title":"Idiopathic inflammatory myopathies and the classical NF-kB complex: current insights and implications for therapy","volume":"8","author":"Creus","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R43-5-20210207","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R44-5-20210207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan","year":"2002","journal-title":"Rheumatology"},{"key":"R45-5-20210207","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine"},{"key":"R46-5-20210207","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival, mortality and causes of death in inflammatory myopathies","volume":"39","author":"Torres","year":"2006","journal-title":"Autoimmunity"},{"key":"R47-5-20210207","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality in polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R48-5-20210207","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005382-199203000-00006","article-title":"Pulmonary and cardiac manifestations of polymyositis-dermatomyositis","volume":"7","author":"Schwarz","year":"1992","journal-title":"J Thorac Imaging"},{"key":"R49-5-20210207","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","article-title":"Adult onset polymyositis\/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature","volume":"15","author":"Hochberg","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"R50-5-20210207","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9149(78)90871-8","article-title":"Cardiac manifestations in polymyositis","volume":"41","author":"Gottdiener","year":"1978","journal-title":"Am J Cardiol"},{"key":"R51-5-20210207","first-page":"373","article-title":"Cardiac manifestations in dermato-polymyositis","volume":"14","author":"Gonzales-Lopez","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"R52-5-20210207","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780221007","article-title":"Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients","volume":"22","author":"Denbow","year":"1979","journal-title":"Arthritis Rheum"},{"key":"R53-5-20210207","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","article-title":"Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology","volume":"109","author":"Mahrholdt","year":"2004","journal-title":"Circulation"},{"key":"R54-5-20210207","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/clc.4960161110","article-title":"The heart in polymyositis: a prospective evaluation of 26 patients","volume":"16","author":"Taylor","year":"1993","journal-title":"Clin Cardiol"},{"key":"R55-5-20210207","first-page":"1779","article-title":"Rheumatic diseases and the heart","author":"Coblyn","year":"1997"},{"key":"R56-5-20210207","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/rheumatology\/38.11.1153","article-title":"Beware of the heart, the multiple picture of cardiac involvement in myositis","volume":"38","author":"Riemekasten","year":"1999","journal-title":"Rheumatology"},{"key":"R57-5-20210207","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.1984.04400020097015","article-title":"ECG abnormalities in polymyositis","volume":"144","author":"Stern","year":"1984","journal-title":"Arch Intern Med"},{"key":"R58-5-20210207","first-page":"809","article-title":"Cardiac manifestations in polymyositis\/dermatomyositis: how to get to the heart of the matter","volume":"22","author":"Lie","year":"1995","journal-title":"J Rheumatol"},{"key":"R59-5-20210207","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0735-1097(98)00397-0","article-title":"Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis: evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis","volume":"32","author":"Kuhl","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R60-5-20210207","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0009-8981(01)00392-8","article-title":"Cardiac troponin and beta type myosin heavy chain concentrations in patients with polymyositis and dermatomyositis","volume":"306","author":"Erlacher","year":"2001","journal-title":"Clin Chem Acta"},{"key":"R61-5-20210207","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/clinchem\/41.12.1710","article-title":"Cardiac troponin I is not expressed in fetal and healthy or diseased adult human skeletal muscle","volume":"41","author":"Bodor","year":"1995","journal-title":"Clin Chem"},{"key":"R62-5-20210207","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/clinchem\/42.12.2033","article-title":"Troponin I immunoenzymometric assays for detection of muscle damage applied to monitoring a triathlon","volume":"42","author":"Rama","year":"1996","journal-title":"Clin Chem"},{"key":"R63-5-20210207","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.59.9.750","article-title":"Serum skeletal troponon I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I","volume":"59","author":"Kiely","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R64-5-20210207","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.97.18.1802","article-title":"Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis","volume":"97","author":"Friedrich","year":"1998","journal-title":"Circulation"},{"key":"R65-5-20210207","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2006.058644","article-title":"Limited effects of high dose intravenous immunoglobulin (IVIg) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies","volume":"66","author":"Barbasso Helmers","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R66-5-20210207","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab","volume":"75","author":"Touma","year":"2008","journal-title":"Joint Bone Spine"},{"key":"R67-5-20210207","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1136\/hrt.82.4.e4","article-title":"Heart transplant for dilated cardiomyopathy associated with polymyositis","volume":"82","author":"Afzal","year":"1999","journal-title":"Heart"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201012000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:16:57Z","timestamp":1786371417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201012000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e32833cdca8","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}